Imran N Siddiqi MD
Hematopathology, Anatomic Pathology, Clinical Pathology
Assistant Professor, Pathology, USC School of Medicine
Join to View Full Profile
2011 Zonal Ave# HmrLos Angeles, CA 90089
Phone+1 323-442-2582
Fax+1 323-442-2588
Dr. Siddiqi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Imran Siddiqi is a pathologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Keck Hospital of USC, Los Angeles Community Hospital at Los Angeles, and USC Norris Comprehensive Cancer Center. He received his medical degree from University of California Irvine School of Medicine and has been in practice 15 years. He specializes in hematopathology, anatomic pathology, and clinical pathology.
Education & Training
University of California (San Francisco)Fellowship, Hematopathology, 2006 - 2007- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 2002 - 2006
University of California, Irvine, School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- T-Cell Prolymphocytic Leukemia With PDGFRB Rearrangement in the Setting of Neurofibromatosis Type 1.Yue Zhao, Philip Petersen, Imran Siddiqi, Endi Wang
International Journal of Laboratory Hematology. 2025-06-01 - Smoothened Inhibitor, PF-04449913 Inhibits the Development of Myelofibrosis in a JAK2V617F Transgenic Mouse Model by Reducing TGF-β and MAPK Signaling Pathways.Akil Merchant, Parvesh Chaudhry, Mohan Singh, Tucker Lemos, Eman Fargal
Research Square. 2025-05-09 - EphB4-ephrin-B2 are targets in castration resistant prostate cancer.Grace Xiuqing Li, Binyun Ma, Shaobing Zhang, Ren Liu, Imran N Siddiqi
British Journal of Cancer. 2025-05-01
Press Mentions
Deadliest Cancers May Respond to New Drug Treatment StrategyJanuary 29th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
